Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.705 USD | -0.55% | +7.20% | +15.02% |
02:23pm | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
05-06 | VYNE Therapeutics Says US FDA Clears its Investigational New Drug Application for Potential Autoimmune Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.02% | 38.35M | |
+32.67% | 698B | |
+26.51% | 568B | |
-4.54% | 358B | |
+19.62% | 328B | |
+3.43% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.97% | 165B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Sector Update: Health Care Stocks Mixed Thursday Afternoon